UNSPSC 51291708: Setazindol

This classification denotes an anorexiant with the molecular formula C15H16ClNO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 92D9H0A3WN, chemically known as alpha-(4-chlorophenyl)-2-((methylamino)methyl)benzenemethanol, hydrochloride but generally known as setazindol, which bears US NIH Compound Identifier 193099. European Medicines Agency schedules Setazindol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10501MIG.

UNSPSC 51291708 Setazindol is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The single recent opportunity on record—Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026—solicits naloxone and safe drug deactivation systems for community health initiatives, a mismatch with the code's pharmaceutical scope. State and local governments do not appear to be actively soliciting setazindol through this code designation at present.

Seminole County, a Florida county health authority, released the only identifiable recent opportunity under this code, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually on an IFB basis with a response deadline of July 26, 2023, and quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The county required electronic bid submission through its e-Procurement Portal, E-Verify compliance, and drug-free workplace certification; the contract offered a two-year initial term with a one-year renewal option. The mismatch between the code designation and the actual procurement scope—combined with the absence of other recent setazindol solicitations across state and local jurisdictions—signals that this code sees minimal or misaligned activity in the current procurement environment.